Catalyst Wire Dossier Catalyst Wire Dossier

Revefenacin

revefenacin · Theravance Biopharma
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Revefenacin, covering 2019-12-18 to 2024-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase 4 COPD and Suboptimal Inspiratory Flow Rate [Phase 4]

See pricing